1. Home
  2. LCFY vs BFRG Comparison

LCFY vs BFRG Comparison

Compare LCFY & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Locafy Limited

LCFY

Locafy Limited

N/A

Current Price

$1.14

Market Cap

8.3M

Sector

N/A

ML Signal

N/A

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

N/A

Current Price

$0.47

Market Cap

8.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
LCFY
BFRG
Founded
2009
2017
Country
Australia
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
8.6M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
LCFY
BFRG
Price
$1.14
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
58.5K
★ 1.1M
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.88
EPS
★ N/A
N/A
Revenue
N/A
★ $116,670.00
Revenue This Year
N/A
$568.55
Revenue Next Year
N/A
$573.08
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 79.49
52 Week Low
$1.10
$0.43
52 Week High
$6.20
$1.96

Technical Indicators

Market Signals
Indicator
LCFY
BFRG
Relative Strength Index (RSI) 24.56 40.24
Support Level $1.10 $0.43
Resistance Level $2.75 $0.69
Average True Range (ATR) 0.13 0.05
MACD -0.02 -0.01
Stochastic Oscillator 8.34 5.87

Price Performance

Historical Comparison
LCFY
BFRG

About LCFY Locafy Limited

Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.

Share on Social Networks: